Adverse Reactions Labelling Pharmacy Management 
Pharmacy Times
JULY 2, 2025
Common adverse reactions included gastrointestinal issues, with a low discontinuation rate due to adverse drug reactions. 2,4 The open-label, single-arm, multicenter, multidose study enrolled 86 patients with CKD and hyperphosphatemia receiving maintenance hemodialysis.
Pharmacy Times
JUNE 12, 2025
3 The safety profile was favorable with the most common adverse effect (AE) being increased creatinine, increased potassium, dysuria, decreased hemoglobin, increased aspartate aminotransferase, increased alanine aminotransferase, increased eosinophils, decreased lymphocytes, urinary tract infection, decreased neutrophils, and hematuria.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 9, 2025
This advancement provides healthcare professionals with improved confidence in managing Alzheimer's disease with donanemab. SHOW MORE FDA approves a new dosing schedule for donanemab, enhancing safety and efficacy in treating early symptomatic Alzheimer disease. million individuals in the United States aged 65 and older.
Digital Pharmacist
OCTOBER 24, 2022
Common adverse reactions include conjunctival/ocular hyperemia, photophobia, blurred vision, dry eye, pain, headache, irritation, and visual impairment. . Rolvedon was supported by data from two Phase 3, randomized, open-label, non-inferiority clinical trials, ADVANCE, and RECOVER, which evaluated safety and efficacy.
Expert insights. Personalized for you.
29 
Let's personalize your content